Vanessa Lemarié, Chief Operations Officer at myTomorrows, which is a platform for connecting patients, physicians, and clinical trial sponsors using a Trial Search AI tool designed to improve the accuracy of matching patients with suitable trials. The technology aims to speed up trial recruitment, increase diversity by reaching underserved populations, and ultimately shorten the drug development timeline. There is a particular focus on patients with no treatment options or who have not responded to current therapies.

Vanessa explains, "We are all about patients. First and foremost, we want to help patients know their options. Patients who turn to us either have no treatment options for their conditions or have exhausted the treatment options. They are looking for alternatives and insights into whether we can help them find, for example, a clinical trial. Physicians who treat those patients turn to us."

"And last but not least, we work with biopharma companies that plan and conduct clinical trials and that sponsor expanded access programs. And those are our clients. So we connect all of those stakeholders. In addition, we work very closely with representative groups of patients and patient advocacy groups to make sure that we are known and to make sure that we understand what specific patient groups might need from companies like ours. So we kind of connect the dots, I guess, and an otherwise somewhat siloed system sometimes, and consider ourselves a platform player. Think of us a little bit like, let's say, booking.com for clinical trials."

#myTomorrows #ClinicalTrials #HealthTech #PatientAccess #RareDiseases #DigitalHealth #Healthcare #Innovation #AI #PatientEmpowerment #Biotechnology #Pharma #MedicalResearch #HealthcareEquity #Technology

mytomorrows.com

Download the transcript here